Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- AdvaMed Releases “AI Policy Roadmap” to Guide Congress and Federal Agencies
- 4/23/2025 9:57:15 AM
- AdvaMed, the Medtech Association, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the next era of artificial intelligence-enabled medical and digital health technologies to provide patients and clinicians transformative new tools to aid in diagnosis and treatment. …
- Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2-positive metastatic breast cancer
- 4/22/2025 1:23:20 PM
- Positive high-level results from a planned interim analysis of the DESTINY-Breast09 Phase III trial showed Enhertu (trastuzumab deruxtecan) in combination with pertuzumab demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to a taxane, trastuzumab and pertuzumab (THP) as a 1st-line treatment for …
- Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA
- 4/22/2025 1:08:18 PM
- TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2) Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study show potential of TAR-200 monotherapy in patients with papillary-only, high-risk non-muscle invasive bladder cancer Johnson & Johnson (NYSE: JNJ) announced that new data …
- Nikon CeLL Innovation Enters into a Strategic License Agreement with RoosterBio, a US Company, to Enable GCTP/GMP Manufacturing Platform of Human Mesenchymal Stem Cells and Extracellular Vesicle in Japan
- 4/15/2025 3:44:54 AM
- Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBio), a leading stem cell technology company in the US.
- Milestone for the medical care of premature babies worldwide
- 4/14/2025 11:53:49 AM
- GenMar Pharma is building a new production facility on the Vion site in Buchloe/Ostallgäu. The facility will produce raw material from bovine lungs for the inhaled emergency treatment of respiratory distress syndrome.
- Do disasters delay early cancer diagnoses?
- 4/14/2025 11:20:00 AM
- Rates of colorectal cancer (CRC) diagnoses dropped during and shortly after Hurricanes Irma and Maria and the COVID-19 pandemic in Puerto Rico, according to a recent analysis.
- Burnout rate improving among physicians, though rates remain high since 2011
- 4/10/2025 7:46:27 AM
- The occupational burnout rate among physicians in the United States continues to moderate after skyrocketing to a record-high in 2021 during the COVID-19 pandemic, according to a newly published study in Mayo Clinic Proceedings.
- AdvaMed Statement on President’s Reciprocal Tariff Pause
- 4/10/2025 7:44:33 AM
- AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker: “We are encouraged by the President’s announcement of a 90-day pause on reciprocal tariffs.
- Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)
- 4/9/2025 9:12:12 AM
- New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label extension phase Up to 128 weeks and 180 patient years of follow-up in the open-label extensiona confirm a safety profile consistent with the Phase 3 Vivacity-MG3 study 45% of …
- MedTechVets Announces Veteran Placement Partnership with Insulet
- 4/8/2025 11:32:01 AM
- MedTechVets, a nonprofit dedicated to helping military veterans transition into the medical technology industry, announces its Veteran Placement Partnership with Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, whose mission is to improve the lives of people with diabetes and other conditions through its Omnipod® delivery system. This …
- AdvaMed Congratulates Dr. Oz on his Confirmation as CMS Administrator
- 4/7/2025 9:43:24 AM
- AdvaMed ®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of the U.S.
- A call to safeguard maternal and newborn health for migrants
- 4/7/2025 9:39:21 AM
- On World Health Day 2025, the United Nations Network on Migration (UNNM), with the World Health Organization (WHO) as a member of its Executive Committee, reaffirms its commitment to ensuring that every pregnant migrant woman, mother and newborn has access to essential health care, regardless of migration status.
- Telehealth and Medicine Today Releases Premier 2025 Issue Featuring the Impact of Digital Health on Chronic Disease Management, Home Health, and Audio Only Care
- 4/7/2025 8:00:00 AM
- Telehealth and Medicine Today (THMT), a leading international open-access peer-reviewed journal, is proud to announce the release of its first issue of 2025.
- Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront
- 4/4/2025 10:33:21 AM
- Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis has completed its acquisition of Anthos Therapeutics in a transaction valued at up to $3.1 billion.
- Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
- 4/3/2025 9:22:58 AM
- Ad hoc announcement pursuant to Art. 53 LR • Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS (Risk Evaluation Mitigation Strategy) program 1 • Phase III data showed Vanrafia achieved proteinuria reduction of 36.1% (P less than 0.0001) vs.
- Edity Therapeutics Enters into a Strategic Co-Development Partnership with Aurigene Oncology to Advance a Novel Cell Therapy Program for Solid Tumors
- 4/3/2025
- Edity Therapeutics Limited and Aurigene Oncology Limited (AOL), a wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited, a clinical-stage biotechnology company, announced a strategic collaboration to create novel cell therapy medicines for difficult-to-treat solid tumors.
- Introducing Mandos: The First Digital Health Platform for the Everyman
- 4/2/2025 12:03:50 PM
- Mandos, a digital health platform built for the everyman, today announced over $1M raised led by Render Capital and Stone Mountain Ventures. The new platform delivers confidence by offering discreet, trusted, and effective treatments for healthcare concerns that strike at the core of male vitality.
- Open Letter of Apology to Lyme Disease Patients Highlights Systemic Failures and Barriers to Care
- 4/1/2025
- A provocative open letter purportedly written by an anonymous Lyme disease “expert” has resurfaced, highlighting the ongoing struggle of millions of Americans suffering from Persistent/Chronic Lyme Disease (PLD/CLD) who face systemic barriers to proper diagnosis, treatment, and support.
- Digital PCR Can Reliably Determine If Chronic Myeloid Leukemia Patients in Remission Can Successfully Discontinue Drug Treatment
- 3/28/2025 11:06:51 AM
- Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be discontinued.
- AdvaMed® Congratulates Dr. Makary on his Confirmation as FDA Commissioner
- 3/27/2025 10:12:29 AM
- AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of the U.S.